PTC
ZBH icon

Philadelphia Trust Company’s Zimmer Biomet ZBH Stock Holding History

Philadelphia Trust Company’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,146
Closed -$602K – 201
2019
Q4 		$602K Sell
4,146
-98
-2% -$13.5K 0.05% 145
2019
Q3 		$566K Buy
4,244
+103
+2% +$13.3K 0.05% 150
2019
Q2 		$473K Hold
4,141
– – 0.04% 164
2019
Q1 		$513K Buy
4,141
+165
+4% +$18.8K 0.05% 154
2018
Q4 		$400K Sell
3,976
-1,318
-25% -$148K 0.04% 141
2018
Q3 		$676K Buy
+5,294
New +$629K 0.06% 134

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Philadelphia Trust Company's ZBH Position: Q1 2020 in Review

Philadelphia Trust Company sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 4,146 shares — an estimated $602K sold.

Philadelphia Trust Company first reported a position in ZBH in Q3 2018 and held it in 6 quarters. The position peaked at $676K in Q3 2018. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Philadelphia Trust Company reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Philadelphia Trust Company sold 4,146 Zimmer Biomet shares in Q1 2020, an estimated $602K.
  • Philadelphia Trust Company first reported a position in Zimmer Biomet in Q3 2018 and held it in 6 quarters.
  • Philadelphia Trust Company's Zimmer Biomet position peaked at $676K in Q3 2018.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Philadelphia Trust Company's 13F filing for Q1 2020, filed 12 May 2020.